MTNB - Matinas BioPharma Holdings, Inc.
0.5282
-0.007 -1.287%
Share volume: 2,764
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$0.54
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 09-30-2024 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q3 2024 | |
| Report Date | 05-10-2023 | 08-09-2023 | 11-08-2023 | 03-27-2024 | 11-13-2024 | |
| Total revenue | 1.096 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.096 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | nan% | nan% | nan% | |||
| Operating expenses | 6.682 M | 6.159 M | 6.134 M | 5.887 M | 4.381 M | |
| Selling general and admin | 2.712 M | 2.600 M | 2.839 M | 2.222 M | 2.142 M | |
| Research and development | 3.970 M | 3.559 M | 3.295 M | 3.665 M | 2.239 M | |
| Total expenses | 6.682 M | 6.159 M | 6.134 M | 5.887 M | 4.381 M | |
| -7.83% | -0.41% | -4.03% | -25.58% | |||
| Operating income | -5.586 M | -6.159 M | -6.134 M | -5.887 M | -4.381 M | |
| Ebit | -5.586 M | -6.159 M | -6.134 M | -5.887 M | -4.275 M | |
| Pretax income | -5.513 M | -6.060 M | -6.055 M | -5.314 M | -4.275 M | |
| 9.92% | -0.08% | -12.24% | -19.55% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -5.513 M | -6.060 M | -6.055 M | -5.314 M | 0.000 | |
| -9.92% | 0.08% | 12.24% | 100.00% | |||
| Net income | -5.513 M | -6.060 M | -6.055 M | -5.314 M | -4.275 M | |
| -9.92% | 0.08% | 12.24% | 19.55% |